Assigning matrix metalloproteinase roles in ischaemic cardiac remodelling.

Abstract

Matrix metalloproteinases (MMPs) and their endogenous inhibitors have been studied in the myocardium for the past 2 decades. An incomplete knowledge base and experimental design issues with inhibitors have hampered attempts at translation, but clinical interest remains high because of strong associations between MMPs and outcomes after myocardial infarction (MI) as well as mechanistic studies showing MMP involvement at multiple stages of the MI wound-healing process. This Review focuses on how our understanding of MMPs has evolved from a one-dimensional early focus on measuring MMP activity, monitoring MMP:inhibitor ratios, and evaluating one MMP-substrate pair to the current use of systems biology approaches to integrate the whole MMP repertoire of roles in the left ventricular response to MI. MMP9 is used as an example MMP to explain these concepts and to provide a template for examining MMPs as mechanistic mediators of cardiac remodelling.

• Authors: Merry L Lindsey
• Journal: Nature reviews. Cardiology (Nat Rev Cardiol) Vol. 15 Issue 8 Pg. 471-479 (08 2018) ISSN: 1759-5010 [Electronic] England
• PMID: 29752454 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, U.S. Gov't, Non-P.H.S., Review)

Chemical References

• Matrix Metalloproteinases

Topics

• Animals
• Heart (physiology, physiopathology)
• Humans
• Matrix Metalloproteinases (metabolism, physiology)
• Mice
• Myocardial Ischemia (metabolism, physiopathology)
• Myocardium (metabolism)
• Rats
• Ventricular Remodeling (physiology)